I agree that this site is using cookies. You can find further informations here.
X
Østenstad, B.
26  results:
Search for persons X
?
1

DIVERSITY OF INTRATUMORAL REGULATORY T CELLS IN B‐CELL NON‐..:

Spasevska, I. ; Sharma, A. ; Steen, C. B....
Hematological Oncology.  41 (2023)  S2 - p. 39-39 , 2023
Link: https://doi.org/10.1002/..
 
?
2

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IB..:

Østenstad, B. ; Pirosa, M. C. ; Schär, S....
Hematological Oncology.  41 (2023)  S2 - p. 117-119 , 2023
Link: https://doi.org/10.1002/..
 
?
3

PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICUL..:

Menter, T. ; Tzankov, A. ; Zucca, E....
Hematological Oncology.  37 (2019)  S2 - p. 149-151 , 2019
Link: https://doi.org/10.1002/..
 
?
4

Increased acquired activated protein C resistance in unsele..:

NEGAARD, H. F. S. ; IVERSEN, P. O. ; ØSTENSTAD, B...
Journal of Thrombosis and Haemostasis.  6 (2008)  9 - p. 1482-1487 , 2008
Link: https://doi.org/10.1111/..
 
?
5

PO-69 Activated protein C (APC) resistance in hematological..:

Negaard, H.F.S. ; Iversen, P.O. ; Ostenstad, B...
Thrombosis Research.  120 (2007)  - p. S167 , 2007
Link: https://doi.org/10.1016/..
 
?
6

A boy with X-linked hyper-IgM syndrome and natural killer c..:

ØSTENSTAD, B ; GILIANI, S ; MELLBYE, O J..
Clinical and Experimental Immunology.  107 (2003)  2 - p. 230-234 , 2003
Link: https://doi.org/10.1111/..
 
?
7

C-erbB-2 expression does not predict response to docetaxel ..:

Sjöström, J ; Collan, J ; von Boguslawski, K...
European Journal of Cancer.  38 (2002)  4 - p. 535-542 , 2002
Link: https://doi.org/10.1016/..
 
?
8

Timing of quality of life (QoL) assessments as a source of ..:

Hakamies-Blomqvist, L. ; Luoma, M.-L. ; Sjostrom, J....
Journal of Advanced Nursing.  35 (2001)  5 - p. 709-716 , 2001
Link: https://doi.org/10.1046/..
 
?
9

Quality of life in patients with metastatic breast cancer r..:

Hakamies-Blomqvist, L ; Luoma, M.-L ; Sjöström, J...
European Journal of Cancer.  36 (2000)  11 - p. 1411-1417 , 2000
Link: https://doi.org/10.1016/..
 
?
10

Docetaxel compared with sequential methotrexate and 5-fluor..:

Sjöström, J. ; Blomqvist, C. ; Mouridsen, H....
European Journal of Cancer.  35 (1999)  8 - p. 1194-1201 , 1999
Link: https://doi.org/10.1016/..
 
?
11

Dose-densified chemoimmunotherapy followed by systemic cent..:

Holte, H ; Leppa, S ; Bjorkholm, M...
https://lup.lub.lu.se/record/3843319.  , 2013
Link: https://lup.lub.lu.se/re..
 
?
12

Entourage: the immune microenvironment following follicular..:

Wahlin, B E ; Sander, B ; Christensson, B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270257.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
13

HER2 expression in breast cancer primary tumours and corres..:

Carlsson, J ; Nordgren, H ; Sjöström, J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409528.  , 2004
Link: http://www.ncbi.nlm.nih...
 
?
14

Tumour microvessel density as predictor of chemotherapy res..:

Tynninen, O ; Sjöström, J ; von Boguslawski, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375425.  , 2002
Link: http://www.ncbi.nlm.nih...
 
?
15

Antigen-specific IgG antibodies in stage IV long-time survi..:

Hansen, M. H ; Ostenstad, B ; Sioud, M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950034.  , 2001
Link: http://www.ncbi.nlm.nih...
 
1-15